H L Hillege - JoVE Visualize

Showing results (21-30 of 57) with videos related to

Pageof 6

Sort By:

Journal of the American College of Cardiology|September 1, 1994

Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombusP den Heijer, D P Foley, J Escaned, et al.

Journal of Cardiovascular Pharmacology|April 1, 1996

Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pigA C Wiesfeld, C D De Langen, H J Crijns, et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 30, 2010

Neurohormonal profile of patients with heart failure and diabetesI C C van der Horst, R A de Boer, H L Hillege, et al.

International Journal of Cardiology|June 1, 2012

Health-related quality of life and anemia in hospitalized patients with heart failureI H Kraai, M L A Luttik, P Johansson, et al.

Clinical Pharmacology and Therapeutics|December 31, 2015

Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulatorsD Postmus, M Mavris, H L Hillege, et al.

European Heart Journal|March 14, 2003

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trialH L Hillege, W H van Gilst, D J van Veldhuisen, et al.

Coronary Artery Disease|March 1, 1996

Angiographic left ventricular wall motion score to predict arrhythmia recurrence in patients with sustained ventricular tachycardia or fibrillationA C Wiesfeld, H J Crijns, S A Van den Broek, et al.

British Heart Journal|May 1, 1994

Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic studyM J de Jongste, J Haaksma, R W Hautvast, et al.

Circulation|July 13, 2000

Renal function, neurohormonal activation, and survival in patients with chronic heart failureH L Hillege, A R Girbes, P J de Kam, et al.

International Journal of Cardiology|June 15, 1994

Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patencyJ Brügemann, J van der Meer, H L Hillege, et al.

Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:

Pageof 6

Journal of the American College of Cardiology|September 1, 1994

Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombusP den Heijer, D P Foley, J Escaned, et al.

Journal of Cardiovascular Pharmacology|April 1, 1996

Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pigA C Wiesfeld, C D De Langen, H J Crijns, et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 30, 2010

Neurohormonal profile of patients with heart failure and diabetesI C C van der Horst, R A de Boer, H L Hillege, et al.

International Journal of Cardiology|June 1, 2012

Health-related quality of life and anemia in hospitalized patients with heart failureI H Kraai, M L A Luttik, P Johansson, et al.

Clinical Pharmacology and Therapeutics|December 31, 2015

Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulatorsD Postmus, M Mavris, H L Hillege, et al.

European Heart Journal|March 14, 2003

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trialH L Hillege, W H van Gilst, D J van Veldhuisen, et al.

Coronary Artery Disease|March 1, 1996

Angiographic left ventricular wall motion score to predict arrhythmia recurrence in patients with sustained ventricular tachycardia or fibrillationA C Wiesfeld, H J Crijns, S A Van den Broek, et al.

British Heart Journal|May 1, 1994

Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic studyM J de Jongste, J Haaksma, R W Hautvast, et al.

Circulation|July 13, 2000

Renal function, neurohormonal activation, and survival in patients with chronic heart failureH L Hillege, A R Girbes, P J de Kam, et al.

International Journal of Cardiology|June 15, 1994

Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patencyJ Brügemann, J van der Meer, H L Hillege, et al.

Pageof 6